α-NETA

α-NETA is a potent and noncompetitive choline acetyltransferase (ChA) inhibitor with an IC50 of 9 μM. α-NETA is a potent ALDH1A1 (IC50=0.04 µM) and chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA weakly inhibits cholinesterase (ChE; IC50=84 µM) and acetylcholinesterase (AChE; IC50=300 µM) . α-NETA has anti-cancer activity[1][2].

Product Specifications

CAS Number

[115066-04-1]

UNSPSC

12352005

Target

Aldehyde Dehydrogenase (ALDH) ; Apoptosis; Chemerin Receptor; Cholinesterase (ChE)

Type

Reference compound

Related Pathways

Apoptosis; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/α-neta.html

Purity

98.0

Solubility

DMSO : 83.33 mg/mL (ultrasonic)

Smiles

O=C(CC[N+](C)(C)C)C1=CC=CC2=C1C=CC=C2.[I-]

Molecular Formula

C16H20INO

Molecular Weight

369.24

References & Citations

[1]Sastry BV, et al. Relationships between chemical structure and inhibition of choline acetyltransferase by 2- (alpha-naphthoyl) ethyltrimethylammonium and related compounds. Pharmacol Res Commun. 1988 Sep;20 (9) :751-71.|[2]Graham KL, et al. A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease. PLoS One. 2014 Dec 1;9 (12) :e112925.|[3]Qiao L, et al. α-NETA induces pyroptosis of epithelial ovarian cancer cells through the GSDMD/caspase-4 pathway. FASEB J. 2019 Nov;33 (11) :12760-12767.